Long non-coding RNAs in anti-cancer drug resistance

@inproceedings{Chen2017LongNR,
  title={Long non-coding RNAs in anti-cancer drug resistance},
  author={Qin-nan Chen and Chen-chen Wei and Zhaoxia Wang and Ming Sun},
  booktitle={Oncotarget},
  year={2017}
}
Chemotherapy is one of the basic treatments for cancers; however, drug resistance is mainly responsible for the failure of clinical treatment. The mechanism of drug resistance is complicated because of interaction among various factors including drug efflux, DNA damage repair, apoptosis and targets mutation. Long non-coding RNAs (lncRNAs) have been a focus of research in the field of bioscience, and the latest studies have revealed that lncRNAs play essential roles in drug resistance in breast… CONTINUE READING
Highly Cited
This paper has 32 citations. REVIEW CITATIONS

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

Crosstalk between long non‐coding RNAs and Wnt/β‐catenin signalling in cancer

Journal of cellular and molecular medicine • 2018
View 1 Excerpt

Emerging role of long non-coding RNAs in cisplatin resistance

OncoTargets and therapy • 2018
View 2 Excerpts

References

Publications referenced by this paper.
Showing 1-10 of 102 references

Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis of bladder cancer.

International journal of oncology • 2012
View 9 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…